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Highlights 
 Blood manganese was associated with the relaxation rate R1 in the globus pallidus. 
 Serum ferritin was a predictor of the relaxation rate R1 in the globus pallidus. 
 Former welders had no increased relaxation rate R1 compared to controls. 
 Respirable Mn above 100 µg/m3 was associated with stronger R1 signals in welders. 
 
 
 
Abstract 
Objective 
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Magnetic resonance imaging is a non-invasive method that allows the indirect quantification of manganese (Mn) and iron (Fe) accumulation in the brain due to 
their paramagnetic features. The WELDOX II study aimed to explore the influence of airborne and systemic exposure to Mn and Fe on the brain deposition using 
the relaxation rates R1 and R2* as biomarkers of metal accumulation in regions of interest in 161 men, including active and former welders. 
Material and methods 
We obtained data on the relaxation rates R1 and R2* in regions that included structures within the globus pallidus (GP), substantia nigra (SN), and white matter 
of the frontal lobe (FL) of both hemispheres, as well as Mn in whole blood (MnB), and serum ferritin (SF). The study subjects, all male, included 48 active and 
20 former welders, 41 patients with Parkinson’s disease (PD), 13 patients with hemochromatosis (HC), and 39 controls. Respirable Mn and Fe were measured 
during a working shift for welders. Mixed regression models were applied to estimate the effects of MnB and SF on R1 and R2*. Furthermore, we estimated the 
influence of airborne Mn and Fe on the relaxation rates in active welders.  
Results 
MnB and SF were significant predictors of R1 but not of R2* in the GP, and were marginally associated with R1 in the SN (SF) and FL (MnB). Being a welder or 
suffering from PD or HC elicited no additional group effect on R1 or R2* beyond the effects of MnB and SF. In active welders, shift concentrations of respirable 
Mn >100 µg/m3 were associated with stronger R1 signals in the GP. In addition to the effects of MnB and SF, the welding technique had no further influence on 
R1. 
Conclusions 
MnB and SF were significant predictors of R1 but not of R2*, indicative of metal accumulation, especially in the GP. Also, high airborne Mn concentration was 
associated with higher R1 signals in this brain region. The negative results obtained for being a welder or for the techniques with higher exposure to ultrafine 
particles when the blood-borne concentration was included into the models indicate that airborne exposure to Mn may act mainly through MnB.  
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1. Introduction 
Occupational exposure to manganese (Mn) has been associated with neurotoxic effects along a continuum of dysfunctions ranging from subclinical 
neurobehavioral effects associated with low Mn exposure to manganism following high exposure (Martin 2006; Mergler et al.  1999). Expert panels, such as the 
German MAK Commission and the American Conference of Governmental Industrial Hygienists (ACGIH) have recommended occupational exposure limits 
(OELs) for respirable Mn as low as 20 µg/m3 (Deveau et al.  2016), and consequently, the German OEL was set to this value in 2015. Compliance with this OEL 
is challenging for welders, in particular when applying high-emission techniques such as gas metal arc welding (GMAW) (Hobson et al.  2011). Given the low 
aerodynamic diameter of particles in welding fumes, most airborne Mn is respirable (Harris et al.  2005; Pesch et al.  2012). The content of ultrafine particles is 
especially high in tungsten inert gas welding (TIG) (Lehnert et al.  2012). 
 
To prevent neurotoxic effects of Mn, OELs should be sufficiently low to avoid brain accumulation of Mn in occupationally exposed workers. In addition, iron 
(Fe), a major constituent of welding fumes that is strongly correlated with airborne Mn (Pesch et al.  2012), plays a prominent role in neurodegeneration (Ward et 
al.  2014). Although both redox-active metals are essential for the development and maintenance of normal brain functions, excess concentrations as a result of 
occupational exposure, aging or disease can induce oxidative damage (Bouabid et al.  2015; Zecca et al.  2004b). An accumulation of Mn in the globus pallidus 
(GP) has been associated with manganism, whereas, the accumulation of redox-active Fe has been observed in the substantia nigra (SN) of patients with 
Parkinson’s disease (PD) (Fasano et al.  2006; Ward et al.  2014; Zecca et al.  2008; Zucca et al.  2015). In the context of magnetic resonance imaging (MRI), 
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paramagnetic metals enhance the relaxation rates R1 and R2* in affected regions of the brain (Fitsanakis et al.  2006). Thus, R1 and R2* have become growingly 
used biomarkers of Mn and Fe accumulation.  
 
Due to their structural similarity, Mn and Fe compete for the same biological transport systems (Fitsanakis et al.  2010). This is reflected in higher blood 
concentrations of Mn (MnB) in subjects with low iron stores in the general population (Kim and Lee 2011; Meltzer et al.  2010; Oulhote et al.  2014). 
Bioavailable Mn and Fe are transported through the capillary endothelium of the blood-brain barrier, and can also enter the brain via the cerebrospinal fluid 
(Bouabid et al.  2015; Yokel 2006). Recent studies have shown that welders have higher blood concentrations of both metals compared to controls, and present 
with increased R1 and R2* in vulnerable brain regions (Lee et al.  2015; Lee et al.  2016). Whether airborne Mn or Fe can enter these brain regions by direct 
influx through the olfactory pathway remains to be investigated. Higher R1 values were also observed in neuroimaging studies with subjects suffering from other 
conditions leading to elevated MnB, such as liver cirrhosis or abuse of Mn-contaminated ephedrone (Maffeo et al.  2013; Poniatowska et al.  2014). Whereas the 
association of brain iron with R2* has been increasingly explored (Haacke et al.  2005b), less is known about the influence of the systemic iron load in terms of 
serum ferritin (SF) on brain iron levels or R2*. Patients with hemochromatosis (HC) are especially of interest as they may present with either increased SF if 
untreated, or with very low SF when regular phlebotomy is applied. Decreased R2* values in iron-rich regions, such as the SN were observed in two HC patients 
(Haba-Rubio et al.  2005).  
 
In addition to occupational exposure limits for airborne exposure to Mn, a biological reference value of 15 µg/L has been set for MnB in Germany. This threshold 
value is the presumed 95th percentile of the distribution in the general population and higher concentrations are thought to be mainly caused by occupational 
exposure (Bonberg et al. 2017). However, no regulation has been issued to control airborne Fe or biomarkers of high iron stores in workers exposed to metal 
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fumes. Welders can present with high SF in addition to elevated MnB (Casjens et al.  2014). Concentrations of SF above 1000 µg/L are predictive of developing 
liver cirrhosis, for example in untreated HC patients (Wang et al.  2010). In addition, patients with liver cirrhosis showed increased MnB and Mn in the basal 
ganglia due to impaired biliary excretion (Krieger et al.  1995). High concentrations of the liver enzyme gamma-glytamyl transpeptidase (GGT) was significantly 
associated with elevated SF in welders (Casjens et al.  2014). This makes the interpretation of SF above normal values difficult in the context of lifestyle (e. g. 
alcohol consumption) and exposure to welding fumes. 
 
Here, we present the MRI results from the WELDOX II study encompassing 161 men with and without exposure to welding fumes in order to explore the 
associations between airborne and  systemic exposure to Mn and Fe with possible accumulation of these metals in specific brain regions using the relaxation rates 
R1 and R2* as MRI-based biomarkers. We included active and former welders as well as controls and enrolled PD and HC patients in order to increase the 
contrast in systemic or brain iron. We adjusted the relaxation rates acquired in both hemispheres for potential liver dysfunction and other covariates. 
 
2. Material and methods 
2.1. Study groups 
Forty-eight male welders - not wearing a powered air-purifying respirator - from 14 companies were recruited between 2013 and 2015. Personal exposure to 
welding fumes was measured in the breathing zone during a working shift. Major techniques were gas metal arc welding (GMAW) (n=22) and tungsten inert gas 
welding (TIG) (n=19). A supplemental questionnaire documented the welding history and included information on welding process, consumable electrode, base 
material, respiratory protection, and other factors. Photos of the workplaces were used to document the efficacy of the local exhaust ventilation. In order to 
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determine MnB after the shift, blood samples were drawn and transported in a cooling box to the laboratory. The neuroimaging of the welders was performed 
with a median lag time of six weeks after this investigation. 
 
We further enrolled 20 former welders with a median time of seven years since their last exposure to welding fume and 39 male controls from the general 
population of the greater Bochum area. Controls were eligible if they never worked as a welder and did not suffer from PD. Forty-one male patients with a 
confirmed diagnosis of PD (DW, SM, LH) who were under treatment from the Department of Neurology, Saint Joseph Hospital in Bochum were included in the 
study (median Hoehn-Yahr score: 2, median UPDRS3 score: 33). Thirteen male HC patients were recruited through a self-help organisation. All except one were 
treated by phlebotomy and did not suffer from liver cirrhosis.  
 
A questionnaire was used to assess socio-demographic characteristics, occupational history, medications and chronic diseases in a face-to-face interview. All 
participants underwent a neurological assessment of movement disorders according to UPDRS3, which was video documented for an independent evaluation by a 
second reading, as well as additional examinations by experienced neurologists (DW, SM, LH). Participants also gave a blood sample to determine MnB (except 
active welders), blood count, iron metabolism, including SF and free serum iron (SFe), GGT and other liver enzymes on the day of neuroimaging at the Institute 
of Clinical Chemistry, Transfusion and Laboratory Medicine of the Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil with methods formerly 
described for the WELDOX study (Casjens et al.  2014). SF was measured by ADVIA Centaur (Siemens, Eschborn, Germany) using a chemiluminometric 
sandwich immunoassay, standardized to WHO standard 80/578. Elevated GGT was considered an indicator of potential liver dysfunction, and carbohydrate-
deficient transferrin (CDT) > 2.6% was presumptive for possible alcohol abuse. 
 
Page 8 of 32
Ac
ce
pte
d M
an
us
cri
pt
8 
 
All participants provided written informed consent prior to participation. The study protocol was approved by the Ethics Committee of the Ruhr University 
Bochum, Germany. 
 
2.2. Airborne exposure to Mn and Fe 
The concentrations of respirable Mn and Fe were determined as formerly described (Pesch et al.  2012). In brief, welders were equipped with PGP-EA samplers 
for collecting respirable particles at a flow rate of 3.5 L/min in the breathing zone (Lehnert et al.  2012). The average duration of the sampling was four hours. Mn 
and Fe were determined by inductively coupled plasma mass spectrometry (ICP-MS) with a Perkin Elmer Elan DRC II (Waltham, Massachusetts). One 
measurement of Mn and four measurements of Fe were below the limits of quantitation (LOQs) and converted to 0.5 * LOQ for statistical analyses. 
 
 
2.3. Determination of manganese in whole blood 
MnB was quantified by means of ICP-MS. To prevent contamination, only plastic materials were used for sample preparation. A reagent blank was included in 
each analytical series. Archived frozen blood samples were thawed and brought to room temperature. Then, 400 µL of whole blood were diluted 1:12.5 with a 
0.5% solution of ammonium hydroxide and 100 µL of a 0.2% solution of Triton-X. Rhodium was used as the internal standard. Analysis was carried out using a 
7700 ICP-MS system from Agilent Technologies (Waldbronn, Germany) in He-mode (flow rate: 5 mL/min) with a collision cell to avoid interferences. Skimmer 
and sampler cones were made of platinum. Calibration and calculation of the analytical result were carried out using standards prepared in sheep blood at eight 
different concentrations. All measurements were above the LOQ of 2.0 µg/L. For internal quality control, we used commercially available material from RECIPE 
(ClinChek Whole Blood Level, lyophil. for Trace Elements I and II, REF 8840, LOT 227) and SERONORM (Trace Elements Whole Blood Level I and II, LOT 
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1103129). Within-series imprecision and between-day imprecision were both lower than 8%. The accuracy of analytical results was ensured by successful 
participation in an international quality assessment scheme for analyses in biological materials. 
 
2.4. MR image acquisition and analysis 
MRI scans were performed on a 3 T Philips Achieva X-series whole-body clinical scanner (Philips Healthcare, Best, The Netherlands) with a 32-channel head 
coil. T1-weighted 3D turbo field echo images (T1 TFE, TR/TE=8.4/3.9 ms, flip angle=8°, bandwidth=191 Hz/pixel, 220 slices, voxel size (1 mm)3 isotropic, 
acquisition matrix: 240 x 240 mm, SENSE factor 2.5) were acquired for anatomical reference. Two fast field echo images (T1 FFE, TR/TE=8.4/3.7 ms, flip 
angles=3° and 17°, band width=191 Hz/pixel, 160 slices, voxel size (1 mm)3 isotropic, acquisition matrix: 256 x 256 mm, SENSE factor 2) were acquired for 
quantitative estimation of R1 (=1/T1) in regions of interest (ROIs). T1 values were calculated by the variable flip angle method (Sabati and Maudsley 2013). 
Dual-TR B1 maps were acquired to correct T1 maps for field inhomogeneity. Five 3D fast field echo images with different echo times (FFE, 
TR/TE/delta_TE=24.3/3.7/4.4 ms, flip angle=20°, bandwidth=287 Hz/pixel, 80 slices, voxel size (1.5 mm)3 isotropic, acquisition matrix: 256 x 256 mm, SENSE 
factor 2) were acquired to estimate R2* (=1/T2*) in the corresponding ROIs. T2* values were calculated by fitting the signal intensity as a function of echo time 
using the exponential decay model (Long et al.  2014). The ROI was measured from one single slice in each case. The R1 and R2* values for each ROI were 
calculated as 1/T1 and 1/T2*, respectively, as the median across each ROI, separately for the left and right hemisphere. ROIs were selected within the GP, SN 
and the white matter of the frontal lobe (FL) of both hemispheres (Figure 1). The placement of the ROI in the white matter of FL was motivated by changes in R1 
observed in primates (Guilarte et al. 2006). We performed the positioning in duplicate and used the arithmetic means of R1 and R2* from both readers for the 
statistical analysis.  
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2.5. Statistics 
Median and inter-quartile range (IQR) were used to describe the distribution of continuous variables in all men or subgroups. As R1 and R2* were acquired in 
both hemispheres, we presented their arithmetic mean for descriptive purposes but analysed the side-specific measurements of the relaxation rates together with 
the hemisphere as the covariate in the regression models. Welders were additionally stratified according to technique (GMAW, TIG and others), exposure to 
respirable Mn (low: <20 µg/m3, medium: 20-100 µg/m3, high: >100 µg/m3) or Fe (low: <25 µg/m3, medium: 25-310 µg/m3, high: >310 µg/m3). Spearman 
correlation coefficients (rs) between airborne, systemic and brain exposure to Mn and Fe were shown with their 95% confidence interval (CI). We applied linear 
mixed models to explore the association of R1 and R2*, respectively, with the study group, and MnB and SF as exposure variables. The subjects were 
implemented as a random factor to consider the dependence of the measurements on the left and right hemisphere. We further ran mixed models to investigate the 
association of R1 and R2* with respirable Mn and Fe in active welders. All models were adjusted for age, GGT, and hemisphere. We additionally implemented 
R2* in the modeling of R1 and vice versa. The calculations were performed with the statistical software SAS, version 9.4 (SAS Institute Inc., Cary, NC, USA). 
 
 
3. Results 
3.1. Characteristics of the study groups 
Table 1 shows the distribution of the socio-demographic characteristics in all men and in the respective study groups. Active welders were younger than former 
welders (median age 51 and 65 years, respectively). Former welders had a median value of seven years since their last exposure to welding fumes (data not 
shown). Patients with PD had an average age of 60 years, and those with HC were on average 56 years of age. Controls were recruited whose ages were within 
the range of those in the different study groups, with a median age of 54 years. Nearly every other active welder was a current smoker, but none of the HC 
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patients was currently smoking. All welders had a blue-collar job as their longest held occupation; whereas, the proportion of blue-collar jobs was 41% in the 
controls, 49% in PD, and 23.1% in HC. Elevated GGT (≥56 U/L) was more frequently observed in welders (35.0% in former welders, 18.8% in active welders) 
than in the other participants (15% in controls and PD patients, 7.7% in HC). Eight men (including six welders) presented with CDT >2.6%. 
 
3.2. Distribution of exposure to Mn 
We assessed exposure to Mn using the shift concentration of respirable Mn in active welders, the systemic burden with MnB, and used R1 as a biomarker of brain 
accumulation in all men. Table 2 shows the medians with IQRs of the distributions of MnB and R1 in the study groups. MnB was highest in active welders (7.7 
µg/L) and lowest in HC patients (6.2 µg/L), with the medians of the other groups ranging between 6.4 and 6.6 µg/L. Two active welders and one HC patient had 
MnB >15 µg/L (data not shown). We observed a corresponding pattern for R1 in the GP, with the highest median in active welders (0.87 1/sec) and the lowest in 
HC (0.81 1/sec). HC patients also showed the lowest median of R1 in the SN; whereas, active welders were within the range of the other groups. Notably, former 
welders did not present with higher R1 values compared to the controls in GP and SN. 
 
Table 3 presents the distribution of respirable Mn and R1 in welders stratified by GMAW as the high-emission technique (22 active and 13 former welders) 
versus TIG and other processes (26 active welders and seven former welders). The median shift exposure to respirable Mn was 68 (IQR 33-140) µg/m3 in 
GMAW, but 5 (IQR 2-23) µg/m3 in TIG and other techniques. The median MnB was 9.2 µg/L in active and 6.3 µg/L in former GMAW welders. The 
corresponding medians were 7.3 µg/L in active and 6.7 µg/L in former welders using TIG or techniques other than GMAW. The medians of R1 were similar in 
both groups among active welders in all ROIs (e.g. GP 0.87, SN 0.76). Active GMAW welders had slightly higher medians of R1 in the GP and FL than former 
GMAW welders. 
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3.3. Distribution of exposure to Fe 
We assessed exposure to Fe with the shift concentration of respirable Fe in active welders, free (SFe) and ferritin-bound Fe (SF) as serum markers and used R2* 
as a biomarker of brain iron accumulation in all men. Table 2 shows the distributions of SFe, SF and R2* in the study groups with median and IQR values. SFe 
was highest in HC (126 µg/dL) and lowest in former welders and PD patients (94 µg/dL and 95 µg/dL, respectively); whereas, an opposite pattern was observed 
for SF (45 µg/L in HC, 113 µg/L in PD, 242 µg/L in former welders). Active welders had SFe concentrations that were similar to controls (103 µg/dL and 105 
µg/dL), but their median SF levels were higher (129 µg/L and 74 µg/L, respectively). Active welders did not exhibit stronger R2* signals compared to controls or 
former welders in any of the ROIs. Notably, PD patients presented with slightly higher medians of R2* in their GP and SN than those with HC or the other 
groups. 
 
Table 3 depicts the distribution of the exposure variables with regard to Fe among welders. The median shift exposure to respirable Fe was 370 (IQR 190-760) 
µg/m3 in GMAW, and 15 (IQR 5-84) µg/m3 in TIG and other techniques. SF but not SFe showed a corresponding pattern in active welders, but with less 
pronounced differences than the airborne concentrations (GMAW: 152 µg/L; TIG and other techniques: 108 µg/L). Former welders who used major techniques 
other than GMAW presented with very high SF (median 460 µg/L). Medians of R2* of all ROIs were quite similar in these subgroups among active or former 
welders. 
 
3.4. Associations between the exposure variables 
In Table 4, we present Spearman rank correlation coefficients with 95% CIs showing the associations between exposure variables in all participants. Correlations 
with airborne Mn and Fe were shown for active welders. Respirable Mn and Fe strongly correlated in welding fumes (rs 0.93, 95% CI 0.88-0.96). Both metals 
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correlated with SF (Mn: rs 0.32, 95% CI 0.04-0.56; Fe: rs 0.36, 95% CI 0.09-0.59), but not with MnB. In all participants, we observed a negative correlation 
between MnB and SFe. Whereas we found indications of weak associations of  MnB with R1 (FL: rs 0.18, 95% CI 0.02-0.33), the correlations between systemic 
iron markers and R1 were less clear. None of the shift measurements of respirable Mn or Fe correlated with R1 or R2*. Also, no significant associations were 
observed between MnB, SF or SFe with any of the R2* measurements. We found moderate correlations between the R1 values of the three ROIs and a strong 
association of the R2* measurements in the GP and SN (rs 0.61, 95% CI 0.50-0.70). With regard to FL, we observed a weak correlation between R1 and R2* (rs 
0.23, 95% CI 0.07-0.38). 
 
3.5. Potential predictors of the relaxation rate R1 in ROIs 
Table 5 presents the effects estimates of potential determinants of R1 adjusted for covariates. MnB was a significant predictor of R1 in the GP (p=0.004), and 
showed a marginal influence on R1 in the FL (p=0.06). SF was associated with R1 in the GP (p=0.005) and SN (p=0.04). We found no additional effect of being 
an active welder or PD patient in comparison to the controls. HC patients presented with marginally lower R1 values in all ROIs, but this observation was based 
on small numbers (FL: p=0.07). Former welders had even slightly lower R1 relaxation times in these ROIs compared to the controls, an observation that was also 
not significant (GP: p=0.08). Furthermore, a higher attained age resulted in lower R1 in the GP (p=0.037) and FL (p<0.001). Furthermore, R1 was associated with 
R2* in the GP (p=0.025). We found no association of GGT with the R1 values in these ROIs. The level-two variance estimates of the mixed models reflect the 
correlations between the R1 values that were acquired in the respective ROIs of both hemispheres. 
 
When restricting this model to active and former welders, MnB and SF remained significant predictors of R1, especially in the GP, but the major welding 
technique (GMAW versus TIG and others) did not additionally influence R1 (Table 6a). Table 6b depicts the effect estimates for airborne Mn on R1 in active 
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welders. We observed higher R1 values in the GP when welders were exposed to respirable Mn above 100 µg/m3 (p=0.01). Again, there was no association of 
GGT with R1. When airborne Mn was substituted by respirable Fe, the R1 signals in the GP were not significantly elevated in welders (data not shown).  
 
3.6. Potential predictors of the relaxation rate R2* 
The data in Table 5 also demonstrate the effect estimates for potential predictors of R2* in the GP, SN and FL. Neither SF nor MnB were significant 
determinants of R2*. When compared to the controls, welders and patients with PD or HC had slightly lower R2* values in their GP, although not significant. 
Former welders and PD patients had somewhat stronger R2* values in the SN, although statistically not significant. Furthermore, a higher attained age resulted in 
an increase of R2* in the GP (p=0.032) and SN (p=0.006). R1 was associated with R2* in the GP (p=0.03) and the FL (p=0.018). The level-two variance 
estimates of the mixed models reflect the correlations between R2* values of the corresponding ROIs of both hemispheres. 
 
As shown in Table 6b, we observed no association between the R2* values and the concentrations of respirable Fe in active welders. Welders assigned to the 
highest tertile of airborne Fe (>310 µg/m3) presented with slightly lower values in the GP and SN as compared to low-exposed welders (<25 µg/m3), although not 
significant. 
 
4. Discussion 
Mn is essential to steel production to improve the workability and hardness of steel, and welding is one of the primary industrial activities to process steel. Based 
on the available evidence that Mn, even at low concentrations, may cause neurotoxic effects, occupational exposure limits were reduced in Germany and other 
countries (Bevan et al.  2017). The majority of GMAW welders in this and the previous WELDOX study were exposed to concentrations of respirable Mn above 
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the current German OEL of 20 µg/m3 (Pesch et al. 2012; Lehnert et al. 2014). An important prerequisite necessary to prevent neurotoxicity is the avoidance of 
brain accumulation of Mn in welders and other at-risk occupations. However, Fe is the major constituent of welding fumes, and welders can present with high SF 
under certain exposure circumstances (Casjens et al. 2014). Although there is mounting evidence that iron metabolism in the brain is implicated in 
neurodegeneration (Rouault 2013), there is yet limited evidence associating the iron metabolism in the blood and brain. Here, we analyzed the association of 
measures of exposure to Mn and Fe with the MRI relaxation rates R1 and R2* as biomarkers for metal accumulation in vulnerable brain regions, such as the GP 
(Lucchini et al.  2000). MnB and SF were found to be significant predictors of R1 in the GP in all men as well as in welders only, with some indication of 
accumulation in other ROIs, including areas within the SN and the white matter of the frontal lobe.  
 
Our statistical models support the hypothesis that exposure to Mn might act via MnB on R1 with the blood-brain barrier as the major path of entry into these 
regions. Subjects with inhalational uptake of Mn, here active welders and in particular TIG welders with exposure to more ultrafine particles, did not show higher 
R1 values in these ROIs when adjusted for MnB and SF. A shift concentration of respirable Mn above 100 µg/m3 was associated with stronger R1 signals in the 
GP compared with concentrations below the current German OEL of 20 µg/m3 for this particle size fraction. Whether airborne Mn acts through elevated MnB on 
R1 or can also enter the brain via olfaction remains to be investigated. 
Slightly lower R1 values in former welders who participated in our neuroimaging study support the notion that occupational exposure to Mn does result in a 
persistent Mn accumulation in the brain. Recovery from Mn-induced R1 signals after cessation of exposure to welding fumes has been observed in welders, as 
well as in experimental animals (Han et al.  2008; Han et al.  2014). However, cross-sectional studies are less informative than longitudinal intervention studies 
on the time course of an accumulation and clearance of Mn in selected brain regions. The limitations of this study design may explain conflicting results on the 
effects of long-term or short-term Mn exposure (Choi et al. 2007, Criswell et al. 2012, Lee et al. 2015).  
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Increased concentrations of MnB have been frequently observed in welders (Ellingsen et al.  2006; Long et al.  2014) and other at-risk occupations (Cowan et al.  
2009; Myers et al.  2003). This finding was also supported in WELDOX II, where active welders had a higher median MnB than other participants. Furthermore, 
the higher concentrations of respirable Mn when using high-emissions techniques such as GMAW in comparison to TIG were reflected in higher MnB as already 
shown in the WELDOX study where we observed a potential overload of the systemic homeostasis of MnB when Mn exceeded 50-100 µg/m3 (Pesch et al.  
2012). This is in line with stronger R1 signals in the GP of welders with respirable Mn above 100 µg/m3 and with the observation of a non-linear brain 
accumulation of Mn in other studies (Lee et al.  2015). Based on published as well as their own data, Baker and coworkers found a non-linear association between 
airborne Mn and MnB and concluded that concentrations of airborne Mn above 10 µg/m3 already result in elevated MnB (Baker et al.  2014). However, various 
differences between these studies, mainly in the sampling of particulate matter in the breathing zone of workers, may impair a sound conclusion on the point of 
departure with regard to the concentration of airborne Mn, which may cause a deviation from the homeostatic regulation of MnB. 
 
Whereas associations of MnB with R1 have been extensively studied, less is known about the significant association between SF and R1, which we could 
demonstrate as a novel finding in the present study. SF can serve as a biomarker of body iron stores, but is additionally affected by inflammation and liver 
dysfunction (Wang et al.  2010). We observed an influence of respirable Fe on SF in the current, as well as in the previous WELDOX study (Casjens et al.  2014; 
Pesch et al.  2012). Mn and Fe are strongly correlated in welding fumes, and their effects on neuroimaging or neurotoxic outcomes cannot be disentangled with 
statistical methods. However, MnB and SF showed only a negligible correlation due to the tight biological regulation of both redox-active metals, which allows a 
better assessment of the effects of the parent metals, Mn and Fe. We also found no associations between welding at high airborne Fe or elevated SF with R2* in 
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the GP, in agreement with a recent study in US welders (Lee et al.  2016). Here, the authors found higher R2* values in the caudate nucleus of welders, an iron-
rich structure, which is highly innervated by dopaminergic neurons that originate from the SN. They also observed a correlation of whole-blood Fe on R2* in this 
region. This finding indicates the accumulation of Fe in vulnerable brain regions of welders, and illustrates the need for more research to explore the association 
between iron metabolism in blood and brain. 
 
Accumulation of iron in the SN and other regions of the brain could be demonstrated in patients with PD and other neurodegenerative diseases with elevated R2* 
or post-mortem tissue analyses (Haacke et al.  2005). In the brain, Fe is also incorporated into ferritin in order to protect against oxidative damage. Ferritin is part 
of the neuromelanin complex, which is highly concentrated in the SN (Zecca et al.  2008). R2* measurements in the SN ranked highest in PD patients who are 
known to show a progressive loss of neuromelanin with the release of Fe (Ayton and Lei 2014; Faucheux et al.  2003). In addition, former welders who presented 
with the highest median SF among all groups showed somewhat higher R2* values in the SN, although this observation was based on small numbers with limited 
statistical power. We further observed an age-related increase in the R1 and R2* measurements in particular in the SN, which may reflect a general release of Fe 
from the neuromelatonin complex during aging (Zecca et al.  2004a). 
 
So far, only a few studies subjected HC patients to neuroimaging in order to determine R1 or R2*, although this is one of the most commonly inherited genetic 
diseases that results in iron overload and liver cirrhosis if untreated (Powell et al.  2016). Most patients of our study were treated with regular phlebotomy, which 
may explain the low concentrations of SF (median 45 µg/L) compared to an average of around 150 µg/L in adult men (Pan and Jackson 2008). A similarly low 
SF concentration was observed in a male HC patient who was treated with phlebotomy and showed decreased R2* values in iron-rich brain regions (Haba-Rubio 
et al.  2005). In contrast to higher MnB in subjects with low SF in the general population (Oulhote et al.  2014), these HC patients presented with the lowest 
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median MnB among all study groups. Only one HC patient with a rare mutation had very high MnB. Low levels of both systemic markers, SF and MnB, may 
explain the lower medians of R1 and R2*, especially in the GP of HC patients compared to the other participants. The concentrations of free serum iron were 
however higher, although the observed effects on the relaxation rates were not significant due to the small number of patients.  
 
High SF is indicative of liver dysfunction, predicts the risk of cirrhosis and is the main clinical manifestation of hemochromatosis (Wang et al. 2010; Powell et al. 
2016). However, welders can also present with elevated SF (Pesch et al.  2012; Powell et al.  2016). In particular, nine out of 20 former welders in this study had 
SF above 300 µg/L. Furthermore, high concentrations of the liver enzyme GGT were associated with elevated SF in a larger group of active welders in the 
previous WELDOX study (Casjens et al.  2014). Furthermore, increased SF was also associated with elevated CDT in welders (Ellingsen et al.  2014). When 
CDT was implemented into the models that were applied to the results of the neurobehavioral tests, the effect that was formerly assigned to Mn could be partially 
explained by the higher alcohol consumption of welders compared with controls (Ellingsen et al.  2008; Ellingsen et al.  2013). Patients with liver cirrhosis have 
on average three times higher MnB than welders, and exhibit hyperintense R1 values (Krieger et al.  1995). However, we found no indication that GGT as marker 
of liver dysfunction influences R1 or R2*. In the present study, six welders were among the eight men with CDT >2.6%, which is commonly considered an 
indicator of alcohol abuse. The role of airborne Fe in iron metabolism in the blood and brain of welders, as well as the possible damage exerted to the liver due to 
chronically elevated SF need to be better explored, also in studies aimed to investigate the neurotoxicity of Mn. In welding fumes, Mn and Fe are strongly 
correlated. Hence, potential metal effects on the relaxations rates or on the results of neurobehavioral tests cannot be disentangled if the exposure assessment is 
based on air measurements only. 
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An advantage of this neuroimaging study is the relatively large study size facing the efforts to investigate volunteering subjects by MRI. The inclusion of 
different study groups such as HC patients enhanced the contrast in the variables under study, which is important for the confirmation of established and the 
identification of novel associations. On the other hand, the cross-sectional design is a limitation of this MRI study, as long-term exposure to these metals cannot 
be assessed with repeated measurements. Although we found relatively strong effects for SF and MnB, the statistical power was not sufficient to estimate 
significant effects in specific subgroups, for example in former welders. New methodological challenges arise when using R1 and R2*. Although relaxation rates 
are commonly used in practice and mostly limited to ROI analyses, they require multi-echo scans that are sensitive to subject motion and other problems. For 
example, the assessment of brain regions with cells that accumulate metals may depend on their exact anatomical brain location. Hence, the manual placing of 
ROIs is subject to the expertise of the observer, which we controlled using independent raters. Small regions like the SN are more difficult to capture than larger 
regions like the GP. Furthermore, a ROI-based analysis of R1 and R2* is limited to a priori selected brain regions of interest, which do not represent the metal 
accumulation throughout the whole brain. Yet, it is known that Mn and Fe can also deposit in other structures of the brain not investigated in our study, such as 
e.g. the caudate (Lee et al. 2016; Criswell et al.  2012; Long et al.  2014). Recent advances include the use of MRI techniques with higher sensitivity, such as 
quantitative susceptibility mapping (QSM) to investigate brain iron (e.g. Acosta-Cabronero et al. 2016).  
 
5. Conclusion 
MnB and SF were independent significant predictors of R1, which is indicative of metal accumulation, especially in the GP. However, none of the investigated 
exposure variables influenced R2* in the ROIs selected for investigation. A concentration of respirable Mn above 100 µg/m3 was associated with stronger R1 
signals in the GP. GMAW welders showed similar R1 values as welders using TIG or other welding techniques when adjusting for MnB or SF, although TIG 
welding generates more ultrafine particles. Our results on the association between blood and brain Mn and Fe metabolism support the hypothesis that the blood-
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brain barrier is the major route of metal transport into the brain. The monitoring of SF and a reduction of high iron stores in active as well as former welders 
should be taken into account as preventive action. 
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Table 1: Characteristics of the study groups of WELDOX II 
 
Total 
N=161 
Welders 
N=48 
Former 
welders 
N=20 
Controls 
N=39 
Parkinson 
disease 
N=41 
Hemochroma-
tosis 
N=13 
Page 25 of 32
Ac
ce
pte
d M
an
us
cri
pt
25 
 
Age (years) [median, inter-quartile range] 56 50-65 51 47-56 65 57-69 54 50-65 60 56-68 56 55-67 
Smoking status [n, %] 
 Never 
 Former 
 Current 
52 
62 
47 
32.3% 
38.5% 
29.2% 
10 
15 
23 
20.8% 
31.3% 
47.9% 
1 
11 
8 
5.0% 
55.0% 
40.0% 
16 
13 
10 
41.0% 
33.3% 
25.6% 
17 
18 
6 
41.7% 
43.9% 
14.6% 
8 
5 
0 
61.5% 
38.5% 
0.0% 
Blue collar worker as longest held occupation [n, %] 107 66.5% 48 100% 20 100% 16 41.0% 20 48.8% 3 23.1% 
Gamma-glutamyl transferase ≥ 56 U/L [n, %] 29 18.0% 9 18.8% 7 35.0% 6 15.4% 6 14.6% 1 7.7% 
Carbohydrate-deficient transferrin > 2.6% [n, %] 8 5.0% 4 8.3% 2 10.0% 2 5.1% 0 0.0% 0 0.0% 
Table 2: Exposure to manganese and iron in the study groups of WELDOX II presented with median and inter-quartile range (all images) 
 
 Total 
N ≤ 161 
Welders 
N ≤ 48 
Former welders 
N ≤ 20 
Controls 
N ≤ 39 
Parkinson patients 
N ≤ 41 
Hemochromatosis 
N ≤ 13 
Manganese in blood 
(µg/L) 
 
6.9 5.8-8.4 7.7 6.8-9.4 6.4 5.6-8.3 6.5 5.9-7.2 6.6 5.4-8.2 6.2 5.1-7.9 
R1 (1/sec) Globus pallidus 0.85 0.81-0.91 0.87 0.84-0.93 0.82 0.78-0.85 0.85 0.82-0.92 0.84 0.80-0.89 0.81 0.79-0.86 
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 Substantia nigra 0.76 0.71-0.80 0.76 0.72-0.80 0.79 0.72-0.83 0.76 0.72-0.80 0.78 0.70-0.82 0.73 0.69-0.77 
 Frontal lobe 0.95 0.90-1.00 0.96 0.93-1.03 0.90 0.88-0.96 0.97 0.91-1.01 0.95 0.90-0.98 0.92 0.86-0.95 
Free serum iron (µg/dL)  103 83-121 103 85-120 94 66-134 105 92-122 95 81-108 126 106-159 
Serum ferritin (µg/L)  112 64-189 129  82-224 242 11-434 74 55-112 113 71-191 45 33-180 
R2* (1/sec) Globus pallidus 41 38-46 40 37-46 41 38-44 43 40-48 44 38-47 39 36-43 
 Substantia nigra 45 39-51 42 39-47 45 41-56 45 40-51 49 40-56 43 40-53 
 Frontal lobe 22 21-23 22 20-23 22 22-23 22 21-24 22 21-23 21 21-22 
R1 and R2*: mean of both hemispheres 
Table 3: Exposure to Mn and Fe in active and former welders by major process (median and inter-quartile range) 
  Gas metal arc welding  with solid and flux-cored wire Tungsten inert gas welding and other techniques 
 
 Active 
N=22 
Former 
N=13 
Active 
N=26 
Former 
N=7 
Respirable Mn (µg/m3)  68 33-140 - .-. 5 2-23 - .-. 
Manganese in blood (µg/L)  9.2 7.1-11.6 6.3 5.5-8.8 7.3 6.6-8.5 6.7 5.6-7.7 
R1 (1/sec) Globus pallidus 0.87 0.85-0.95 0.81 0.79-0.85 0.87 0.83-0.91 0.84 0.76-0.88 
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 Substantia nigra 0.76 0.73-0.80 0.74 0.71-0.81 0.76 0.71-0.78 0.80 0.77-0.84 
 Frontal lobe 0.95 0.92-1.03 0.88 0.88-0.95 0.97 0.94-1.03 0.96 0.90-1.00 
Respirable Fe (µg/m3)  370 190-760 - .-. 15 5-84 - .-. 
Free serum iron (µg/dL)  97 84-111 92 63-140 106 85-126 104 78-128 
Serum ferritin (µg/L)  152 122-273 140 89-347 108 53-173 460 185-1080 
R2* (1/sec) Globus pallidus 40 36-44 42 38-43 40 37-47 41 38-45 
 Substantia nigra 44 38-46 45 41-55 41 39-47 45 43-57 
 Frontal lobe 22 20-23 22 22-23 22 21-24 22 21-23 
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Table 4: Spearman correlation coefficients with 95% confidence intervals between exposure variables in 161 men of WELDOX II (correlations with 
respirable Mn and Fe in 41 active welders) 
rs (95%CI) MnB R1 GP R1 SN R1 FL AirFe SFe SF R2* GP R2* SN R2* FL 
Respirable Mn 
(µg/m3) 
0.10 (-0.19; 
0.37) 
0.05 (-0.25; 
0.33) 
0.16 (-0.13; 
0.43) 
-0.15 (-0.42; 
0.15) 
0.93 (0.88; 
0.96) 
0.14 (-0.15; 
0.41) 
0.32 (0.04; 
0.56) 
-0.11 (-0.38; 
0.18) 
-0.20 (-0.46; 
0.09) 
0.08 (-0.21; 
0.36) 
Mn in blood 
(µg/L) (MnB) 
 
0.15 (-0.01; 
0.31) 
0.14 (-0.03; 
0.29) 
0.18 (0.02; 
0.33) 
0.12 (-0.17; 
0.39) 
-0.25 (-0.39; -
0.10) 
-0.12 (-0.27; 
0.04) 
-0.06 (-0.21; 
0.10) 
-0.14 (-0.29; 
0.02) 
0.09 (-0.06; 
0.25) 
R1 Global 
pallidus (GP) 
  
0.32 (0.16; 
0.46) 
0.50 (0.37; 
0.62) 
0.00 (-0.29; 
0.29) 
0.02 (-0.15; 
0.18) 
-0.10 (-0.26; 
0.07) 
0.02 (-0.14; 
0.18) 
0.02 (-0.15; 
0.18) 
0.23 (0.07; 
0.38) 
R1 Substantia 
nigra (SN) 
   
0.25 (0.09; 
0.39) 
0.15 (-0.14; 
0.42) 
-0.08 (-0.24; 
0.09) 
0.09 (-0.07; 
0.25) 
0.10 (-0.06; 
0.26) 
0.14 (-0.02; 
0.30) 
0.06 (-0.10; 
0.22) 
R1 Frontal lobe 
(FL) 
    
-0.14 (-0.42; 
0.15) 
0.07 (-0.10; 
0.23) 
-0.14 (-0.30; 
0.03) 
0.06 (-0.11; 
0.22) 
-0.05 (-0.21; 
0.12) 
0.23 (0.07; 
0.38) 
Respirable Fe 
(µg/m3) (AirFe) 
     
0.06 (-0.22; 
0.34) 
0.36 (0.09; 
0.59) 
-0.11 (-0.38; 
0.18) 
-0.24 (-0.49; 
0.05) 
-0.03 (-0.31; 
0.26) 
Free serum Fe 
(µg/dL) (SFe) 
      
0.14 (-0.01; 
0.29) 
0.08 (-0.08; 
0.23) 
0.04 (-0.11; 
0.20) 
0.11 (-0.05; 
0.26) 
Serum ferritin 
(µg/L) (SF) 
       
0.08 (-0.08; 
0.23) 
-0.02 (-0.17; 
0.14) 
-0.08 (-0.23; 
0.07) 
R2* GP         
0.61 (0.50; 
0.70) 
0.00 (-0.15; 
0.15) 
R2* SN          
-0.02 (-0.18; 
0.13) 
Table 5: Potential predictors of the R1 and R2* relaxation rates in ROIs in 161 male participants of WELDOX II 
Factor R1 (1/sec) R2* (1/sec) 
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Globus pallidus Substantia nigra Frontal lobe Globus pallidus Substantia nigra Frontal lobe  
 P  P  P  P  P  P 
Intercept 0.881  0.684  1.041  16.7  17.4  19.2  
Controls (reference group) 0  0  0  0  0  0  
Active welders 0.011 0.600 -0.003 0.890 -0.016 0.370 -0.555 0.830 0.062 0.980 -0.510 0.260 
Former welders -0.046 0.080 -0.001 0.980 -0.031 0.150 -1.657 0.600 3.168 0.410 0.639 0.240 
Parkinson patients -0.009 0.670 0.014 0.470 -0.006 0.740 -1.030 0.690 4.252 0.180 0.609 0.170 
Haemochromatosis patients -0.014 0.610 -0.024 0.330 -0.042 0.070 -4.026 0.230 0.355 0.930 -0.304 0.600 
Age [per 10 years] -0.020 0.037 0.003 0.770 -0.029 <0.001 2.556 0.032 3.952 0.006 -0.245 0.240 
Mn in blood [per 10 µg/L] 0.070 0.004 0.035 0.110 0.039 0.060 -1.851 0.540 -2.309 0.520 0.373 0.470 
Serum ferritin [per 100 µg/L] 0.011 0.005 0.007 0.040 0.002 0.590 -0.288 0.540 -0.846 0.130 -0.075 0.340 
R1 (1/sec)       17.1 0.030 12.6 0.210 4.441 0.018 
R2* (1/sec) 0.001 0.025 0.000 0.210 0.002 0.200       
GGT [per 10 U/L] -0.002 0.180 0.001 0.460 -0.001 0.440 0.097 0.590 0.017 0.940 -0.001 0.970 
Left versus right hemisphere -0.011 0.038 -0.005 0.270 0.031 <0.001 0.631 0.360 0.061 0.930 -0.119 0.590 
Random effects             
Level-two variance estimate  0.006 <0.001 0.005 <0.001 0.004 <0.001 88.7 <0.001 134.6 <0.001 1.526 <0.001 
Level-one variance estimate 0.002 <0.001 0.001 <0.001 0.002 <0.001 33.9 <0.001 34.6 <0.001 3.162 <0.001 
 
  
Table 6: Potential predictors of the R1 and R2* relaxation rates in ROIs in welders of WELDOX II 
a) Welding technique, Mn in blood and serum ferritin (active and former welders) 
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R1 (1/sec) R2* (1/sec) 
Globus pallidus Substantia nigra Frontal lobe Globus pallidus Substantia nigra Frontal lobe 
Factor 
 P  P  P  P  P  P 
Intercept 0.891  0.673  0.999  13.0  11.8  14.1  
TIG or other techniques 0  0  0  0  0  0  
GMAW or FCAW 0.016 0.51 0.002 0.91 -0.025 0.16 -1.736 0.57 -0.045 0.99 -0.125 0.77 
Mn in blood [per 10 µg/L] 0.113 <0.001 0.039 0.13 0.050 0.03 -2.695 0.51 -0.146 0.97 -0.360 0.53 
Serum ferritin [per 100 µg/L] 0.013 0.01 0.008 0.041 0.003 0.39 -0.445 0.45 -0.605 0.28 -0.079 0.34 
R1 (1/sec) - - - - - - 26.9 0.021 10.5 0.45 7.198 0.01 
R2* (1/sec) 0.002 0.017 0.000 0.55 0.003 0.11 - - - - - - 
Age [per 10 years] -0.037 0.023 0.004 0.76 -0.031 0.007 1.670 0.39 4.787 0.011 0.298 0.29 
GGT [per 10 U/L] -0.003 0.19 0.001 0.48 -0.000 0.72 0.231 0.32 0.186 0.40 -0.017 0.61 
Left versus right hemisphere -0.009 0.26 -0.006 0.33 0.031 <0.001 1.233 0.28 0.437 0.68 0.086 0.80 
Random effects             
Level-two variance estimate  0.009 <0.001 0.006 <0.001 0.004 <0.001 126.9 <0.001 116.9 <0.001 1.131 0.036 
Level-one variance estimate 0.002 <0.001 0.001 <0.001 0.001 <0.001 42.4 <0.001 38.1 <0.001 3.666 <0.001 
 
 
b) Respirable Mn or Fe (active welders) 
R1 (1/sec) R2* (1/sec) 
Globus pallidus Substantia nigra Frontal lobe Globus pallidus Substantia nigra Frontal lobe 
Factor 
 P  P  P  P  P  P 
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Intercept 0.674  0.652  1.056  26.4  19.2  16.3  
Respirable Mn  < 20 µg/m3 0  0  0        
20 – 100 µg/m3 0.017 0.68 -0.009 0.76 -0.027 0.31 - - - - - - 
   >100 µg/m3 0.123 0.01 0.049 0.16 -0.009 0.78 - - - - - - 
Respirable  Fe  < 25 µg/m3       0  0  0  
25-310 µg/m3 - - - - - - -2.752 0.54 0.440 0.88 -0.354 0.60 
> 310 µg/m3 - - - - - - -7.095 0.14 -5.563 0.08 0.123 0.86 
R1 (1/sec) - - - - - - 37.3 0.004 23.2 0.07 6.375 0.07 
R2* (1/sec) 0.003 <0.001 0.001 0.12 0.001 0.64 - - - - - - 
Age [per 10 years] 0.017 0.60 0.009 0.71 -0.022 0.31 -2.929 0.41 1.771 0.46 -0.101 0.85 
GGT [per 10 U/L] -0.002 0.36 0.002 0.30 -0.000 0.99 0.003 0.99 -0.177 0.33 -0.031 0.45 
Left versus right hemisphere -0.007 0.43 -0.013 0.08 0.029 <0.001 2.204 0.08 0.298 0.81 0.327 0.46 
Random effects          
Level-two variance estimate  0.013 <0.001 0.007 <0.001 0.005 <0.001 130.9 <0.001 50.0 <0.001 1.189 0.08 
Level-one variance estimate 0.002 <0.001 0.001 <0.001 0.001 <0.001 35.7 <0.001 34.1 <0.001 4.201 <0.001 
 
 
 
Figure 1: Regions of interest including the globus pallidus, substantia nigra and the white matter of the frontal lobe 
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